NİZAM, E. Et Al. 2020. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences. CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.69, no.8 , 1639-1650.

NİZAM, E., KÖKSOY, S., & ERİN, N., (2020). NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences. CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.69, no.8, 1639-1650.

NİZAM, ESRA, SADİ KÖKSOY, And NURAY ERİN. "NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences," CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.69, no.8, 1639-1650, 2020

NİZAM, ESRA Et Al. "NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences." CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.69, no.8, pp.1639-1650, 2020

NİZAM, E. KÖKSOY, S. And ERİN, N. (2020) . "NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences." CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.69, no.8, pp.1639-1650.

@article{article, author={ESRA TAVŞAN Et Al. }, title={NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences}, journal={CANCER IMMUNOLOGY IMMUNOTHERAPY}, year=2020, pages={1639-1650} }